Publicaciones en colaboración con investigadores/as de Hospital Nossa Senhora da Conceição (2)

2024

  1. Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial

    Nature Medicine, Vol. 30, Núm. 8, pp. 2208-2215

2022

  1. Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

    New England Journal of Medicine, Vol. 386, Núm. 12, pp. 1142-1154